NasdaqGS - Delayed Quote • USD
PetIQ, Inc. (PETQ)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 4:01 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,101,963.00
1,101,963.00
921,513.00
932,528.00
780,051.00
Cost of Revenue
849,223.00
849,223.00
711,850.00
746,135.00
644,863.00
Gross Profit
252,740.00
252,740.00
209,663.00
186,393.00
135,188.00
Operating Expense
196,236.00
196,236.00
182,561.00
170,521.00
138,375.00
Operating Income
56,504.00
56,504.00
27,102.00
15,872.00
-3,187.00
Net Non Operating Interest Income Expense
-34,547.00
-34,547.00
-27,374.00
-24,696.00
-22,807.00
Other Income Expense
-19,591.00
-19,591.00
-47,134.00
-3,690.00
680.00
Pretax Income
2,366.00
2,366.00
-47,406.00
-12,514.00
-25,314.00
Tax Provision
-173.00
-173.00
1,214.00
3,869.00
60,413.00
Net Income Common Stockholders
2,131.00
2,131.00
-48,208.00
-15,967.00
-82,655.00
Diluted NI Available to Com Stockholders
2,131.00
2,131.00
-48,208.00
-15,967.00
-82,655.00
Basic EPS
0.07
--
-1.65
-0.57
-3.15
Diluted EPS
0.07
--
-1.65
-0.57
-3.15
Basic Average Shares
29,135.00
--
29,159.00
28,242.00
24,629.00
Diluted Average Shares
29,530.00
--
29,159.00
28,242.00
24,629.00
Total Operating Income as Reported
37,073.00
37,073.00
-20,162.00
15,872.00
-3,187.00
Total Expenses
1,045,459.00
1,045,459.00
894,411.00
916,656.00
783,238.00
Net Income from Continuing & Discontinued Operation
2,131.00
2,131.00
-48,208.00
-15,967.00
-82,655.00
Normalized Income
17,481.49
17,481.49
-10,869.44
-11,986.31
-82,655.00
Interest Expense
34,547.00
34,547.00
27,374.00
24,696.00
22,807.00
Net Interest Income
-34,547.00
-34,547.00
-27,374.00
-24,696.00
-22,807.00
EBIT
36,913.00
36,913.00
-20,032.00
12,182.00
-2,507.00
EBITDA
81,411.00
81,411.00
15,436.00
51,482.00
24,976.00
Reconciled Cost of Revenue
849,223.00
849,223.00
711,850.00
746,135.00
644,863.00
Reconciled Depreciation
44,498.00
44,498.00
35,468.00
39,300.00
27,483.00
Net Income from Continuing Operation Net Minority Interest
2,131.00
2,131.00
-48,208.00
-15,967.00
-82,655.00
Total Unusual Items Excluding Goodwill
-19,431.00
-19,431.00
-47,264.00
-5,453.00
--
Total Unusual Items
-19,431.00
-19,431.00
-47,264.00
-5,453.00
--
Normalized EBITDA
100,842.00
100,842.00
62,700.00
56,935.00
24,976.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-4,080.51
-4,080.51
-9,925.44
-1,472.31
--
12/31/2020 - 7/21/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ELAN Elanco Animal Health Incorporated
13.26
+1.69%
LFCR Lifecore Biomedical, Inc.
6.60
-0.68%
PAHC Phibro Animal Health Corporation
12.73
+2.33%
COLL Collegium Pharmaceutical, Inc.
36.42
+1.62%
CTLT Catalent, Inc.
55.92
+0.22%
IRWD Ironwood Pharmaceuticals, Inc.
7.82
-3.22%
INDV Indivior PLC
17.58
+1.91%
KMDA Kamada Ltd.
5.15
-0.96%
HCM HUTCHMED (China) Limited
18.16
-4.37%
ALKS Alkermes plc
24.68
+0.98%